LDL-lowering versus LDL eradication; what makes clinical sense

28 August 2018 (13:20 - 13:35)

Organised by:

About the speaker

Professor John Kastelein

Academic Medical Centre, Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Introduction - New concepts and models in cardiovascular risk management

Professor P. Libby (Boston, US) Professor J. Deanfield (London, GB)

Presentation thumbnail

Challenges and models in cardiovascular risk management - Start early, invest in your arteries

Professor J. Deanfield (London, GB)

Presentation thumbnail

Precision medicine and tools in high cardiovascular risk patients

Professor F. Visseren (Utrecht, NL)

Presentation thumbnail

Panel discussion - New concepts and models in cardiovascular risk management

Professor P. Libby (Boston, US) Professor J. Deanfield (London, GB)

Access the full session

Session thumbnail

New concepts and models in cardiovascular risk management (EBAC Accredited)

The Event

ESC Congress 2018

28 August 2018 13:20 CET

You may be interested in

Congress Presentation

Residual cardiovascular risk of patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy

27 August 2021

Congress Session

Optimising cholesterol levels through dietary interventions: key strategies and evidence

23 June 2023

Congress Presentation

Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy

24 June 2023

Congress Presentation

The COR Lipid-Registry: The effectiveness of the strike early and strike strong strategy (SES) in patients with high cardiovascular risk

20 March 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources